(Q44433649)

English

Studies on the Interactions between Drug and Estrogen. II. On the Inhibitory Effect of 29 Drugs Reported to Induce Gynecomastia on the Oxidation of Estradiol at C-2 or C-17

scientific article published on May 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Studies on the Interactions between Drug and Estrogen. II. On the Inhibitory Effect of 29 Drugs Reported to Induce Gynecomastia on the Oxidation of Estradiol at C-2 or C-17 (English)

1 reference

10.1248/BPB.26.695

https://api.crossref.org/works/10.1248/BPB.26.695

31 December 2023

adverse drug reaction

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12736515

31 December 2023

pharmaceutical science

1 reference

10.1248/BPB.26.695

https://api.crossref.org/works/10.1248/BPB.26.695

31 December 2023

1 reference

10.1248/BPB.26.695

https://api.crossref.org/works/10.1248/BPB.26.695

31 December 2023

author name string

Takashi Satoh

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Haruka Munakata

2

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Ken-ichi Fujita

3

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Shinji Itoh

4

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Shungo Itoh

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Tetsuya Kamataki

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Itsuo Yoshizawa

7

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Biological and Pharmaceutical Bulletin

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

695-700

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Studies on the interactions between drugs and estrogen: analytical method for prediction system of gynecomastia induced by drugs on the inhibitory metabolism of estradiol using Escherichia coli coexpressing human CYP3A4 with human NADPH-cytochrome P

1

1 reference

10.1248/BPB.26.695

https://api.crossref.org/works/10.1248/BPB.26.695

31 December 2023

High catalytic activity of human cytochrome P450 co-expressed with human NADPH-cytochrome P450 reductase in Escherichia coli

7

1 reference

10.1248/BPB.26.695

https://api.crossref.org/works/10.1248/BPB.26.695

31 December 2023

On the inhibitory action of 29 drugs having side effect gynecomastia on estrogen production

8

1 reference

10.1248/BPB.26.695

https://api.crossref.org/works/10.1248/BPB.26.695

31 December 2023

Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues

9

1 reference

10.1248/BPB.26.695

https://api.crossref.org/works/10.1248/BPB.26.695

31 December 2023

Role of cytochrome P450 enzymes in drug-drug interactions.

10

1 reference

10.1248/BPB.26.695

https://api.crossref.org/works/10.1248/BPB.26.695

31 December 2023

P450 enzymes of estrogen metabolism

11

1 reference

10.1248/BPB.26.695

https://api.crossref.org/works/10.1248/BPB.26.695

31 December 2023

Functional role of estrogen metabolism in target cells: review and perspectives

12

1 reference

10.1248/BPB.26.695

https://api.crossref.org/works/10.1248/BPB.26.695

31 December 2023

Intracrinology: role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and disease

13

1 reference

10.1248/BPB.26.695

https://api.crossref.org/works/10.1248/BPB.26.695

31 December 2023

Effects of arachidonic acid, prostaglandins, retinol, retinoic acid and cholecalciferol on xenobiotic oxidations catalysed by human cytochrome P450 enzymes

14

1 reference

10.1248/BPB.26.695

https://api.crossref.org/works/10.1248/BPB.26.695

31 December 2023

Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture

15

1 reference

10.1248/BPB.26.695

https://api.crossref.org/works/10.1248/BPB.26.695

31 December 2023

Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme.

16

1 reference

10.1248/BPB.26.695

https://api.crossref.org/works/10.1248/BPB.26.695

31 December 2023

Sterochemistry of estrogen biosynthesis

17

1 reference

10.1248/BPB.26.695

https://api.crossref.org/works/10.1248/BPB.26.695

31 December 2023

Ketoconazole, cyclosporin metabolism, and renal transplantation

19

1 reference

10.1248/BPB.26.695

https://api.crossref.org/works/10.1248/BPB.26.695

31 December 2023

Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions

23

1 reference

10.1248/BPB.26.695

https://api.crossref.org/works/10.1248/BPB.26.695

31 December 2023

Effect of Flutamide on Estradiol Metabolism*

25

1 reference

10.1248/BPB.26.695

https://api.crossref.org/works/10.1248/BPB.26.695

31 December 2023

Characteristics of human types 1, 2 and 3 17 beta-hydroxysteroid dehydrogenase activities: oxidation/reduction and inhibition

27

1 reference

10.1248/BPB.26.695

https://api.crossref.org/works/10.1248/BPB.26.695

31 December 2023

Spironolactone-related inhibitors of type II 17beta-hydroxysteroid dehydrogenase: chemical synthesis, receptor binding affinities, and proliferative/antiproliferative activities

28

1 reference

10.1248/BPB.26.695

https://api.crossref.org/works/10.1248/BPB.26.695

31 December 2023

Specific radioimmunoassay of estrone sulfate. Application to measurement in male plasma

29

1 reference

10.1248/BPB.26.695

https://api.crossref.org/works/10.1248/BPB.26.695

31 December 2023

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

30

1 reference

10.1248/BPB.26.695

https://api.crossref.org/works/10.1248/BPB.26.695

31 December 2023

Risk of gynaecomastia associated with cimetidine, omeprazole, and other antiulcer drugs

31

1 reference

10.1248/BPB.26.695

https://api.crossref.org/works/10.1248/BPB.26.695

31 December 2023

Identifiers

10.1248/BPB.26.695

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

release_fmpp7oysazdtxnbevmdh47tmtu

1 reference

https://api.fatcat.wiki/v0/release/fmpp7oysazdtxnbevmdh47tmtu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44433649&oldid=2041451741"